PFG Advisors
WST icon

PFG Advisors’s West Pharmaceutical WST Stock Holding History

PFG Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11M Buy
2,990
+1
+0% +$353 0.06% 351
2026
Q2 		$1.07M Hold
2,989
– – 0.05% 364
2026
Q1 		$749K Sell
2,989
-65
-2% -$16.2K 0.04% 448
2025
Q4 		$840K Sell
3,054
-248
-8% -$67.8K 0.04% 413
2025
Q3 		$866K Buy
3,302
+50
+2% +$12.2K 0.04% 426
2025
Q2 		$712K Sell
3,252
-9
-0.3% -$1.92K 0.03% 354
2025
Q1 		$730K Buy
3,261
+1
+0% +$276 0.04% 389
2024
Q4 		$1.07M Sell
3,260
-351
-10% -$110K 0.07% 291
2024
Q3 		$1.08M Buy
3,611
+6
+0.2% +$1.84K 0.07% 287
2024
Q2 		$1.19M Sell
3,605
-20
-0.6% -$7.07K 0.08% 262
2024
Q1 		$1.43M Sell
3,625
-3
-0.1% -$1.11K 0.1% 221
2023
Q4 		$1.28M Sell
3,628
-4
-0.1% -$1.42K 0.1% 223
2023
Q3 		$1.36M Sell
3,632
-1
-0% -$387 0.12% 197
2023
Q2 		$1.39M Buy
3,633
+6
+0.2% +$2.14K 0.11% 226
2023
Q1 		$1.26M Buy
3,627
+1
+0% +$292 0.11% 232
2022
Q4 		$853K Hold
3,626
– – 0.08% 275
2022
Q3 		$892K Hold
3,626
– – 0.1% 242
2022
Q2 		$1.1M Buy
3,626
+29
+0.8% +$9.44K 0.12% 161
2022
Q1 		$1.48M Hold
3,597
– – 0.15% 147
2021
Q4 		$1.69M Buy
3,597
+2,579
+253% +$1.11M 0.17% 177
2021
Q3 		$432K Buy
1,018
+400
+65% +$169K 0.05% 355
2021
Q2 		$222K Buy
+618
New +$204K 0.03% 448
2021
Q1 		– Sell
-771
Closed -$218K – 473
2020
Q4 		$218K Buy
771
+81
+12% +$22.7K 0.04% 347
2020
Q3 		$202K Buy
+690
New +$183K 0.04% 341

Other funds holding WST

ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

PFG Advisors's WST Position: Q3 2026 in Review

PFG Advisors increased its West Pharmaceutical (WST) stake by 0.03% in Q3 2026, buying an estimated $353 and bringing the position to 2,990 shares worth $1.11M. The position accounts for 0.06% of the portfolio, ranked #351.

PFG Advisors first reported a position in WST in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.69M in Q4 2021. 273 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • PFG Advisors held 2,990 shares of West Pharmaceutical worth $1.11M as of Q3 2026.
  • PFG Advisors bought 1 West Pharmaceutical share in Q3 2026, an estimated $353.
  • West Pharmaceutical made up 0.06% of PFG Advisors's portfolio in Q3 2026, its #351 holding.
  • PFG Advisors first reported a position in West Pharmaceutical in Q3 2020 and has held it in 24 quarters since.
  • PFG Advisors's West Pharmaceutical position peaked at $1.69M in Q4 2021.
  • 273 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.